Home › Idiopathic Hypersomnia › Georgia
Pag-aaral pangklinika para sa Idiopathic Hypersomnia sa Georgia
6 pag-aaral para sa Idiopathic Hypersomnia ang naghahanap ng mga kalahok sa mga site sa Georgia.
Mga Lungsod sa Georgia
Opisyal na teksto ng pag-aaral (English)
A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)
- NeuroTrials Research Inc., Atlanta
- Sleep Practitioners, LLC, Macon
- Southeast Lung Associates Research, Rincon
- at 1 pa
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT07500090A Study of TAK-360 in People With Narcolepsy or Idiopathic Hypersomnia
- Takeda Site 6, Atlanta
Nagre-recruitPhase 2/3
Edad 18 hanggang 71 · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT07646678A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
- Alkermes Investigational Site, Atlanta
- Alkermes Investigational Site, Macon
- Alkermes Investigational Site, Stockbridge
Nagre-recruitPhase 2/3
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Okt 9, 2026 · NCT06767683A Study Evaluating the Efficacy and Safety of Xywav Expanded Dosing vs Placebo in Participants With Narcolepsy or IH
- Centricity Research Rincon - DBA IACT Health Southeast Lung Associates Research, Rincon
Nagre-recruitPhase 3
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Okt 8, 2026 · NCT07625280A Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
- Atlanta, Georgia, Atlanta
- Atlanta, Georgia, Atlanta
- Riverdale, Georgia, Riverdale
Nagre-recruitPhase 2
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Abr 27, 2026 · NCT06752668A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
- Stockbridge, GA, Atlanta
- Atlanta, Georgia, Atlanta
Nagre-recruitPhase 2
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Abr 16, 2026 · NCT07096674Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.